Health
Sanofi CEO: mRNA is likely the ‘go-to’ vaccine tech for a pandemic, but the ‘bar is high’ in other diseases – FiercePharma
In the global COVID-19 vaccine race, mRNA vaccines quickly got out to the front of the pack and two reached distribution in less than a year. But their quick success…
In the global COVID-19 vaccine race, mRNA vaccines quickly got out to the front of the pack and two reached distribution in less than a year. But their quick success in COVID-19 doesn’t guarantee mRNA will replace traditional vaccine technologies across the industry, Sanofi CEO Paul Hudson told Barrons.
During a single-antigen pandemic, where speed is a key consideration, “I think we have to accept that … mRNA is probably the first go-to,” Hudson told the publication. But in disease areas where…
-
General22 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News7 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News7 hours agoFatal traffic crash, Noosa – Sunshine Coast
-
Noosa News23 hours agoBrisbane widow’s $6 million prize home win comes with unexpected luxury